Dr. Fred Adomako-Boateng Calls for Hepatitis B Birth-Dose Vaccine to Curb Transmission in Ghana

Dr. Fred Adomako-Boateng, the Ashanti Regional Director of Health Services, has issued a powerful call for the removal of systemic barriers to hepatitis prevention and treatment in Ghana. Speaking at an event commemorating World Hepatitis Day, Dr. Adomako-Boateng revealed the staggering scale of the health crisis, noting that over three million Ghanaians are currently living with chronic Hepatitis B and C. He emphasized that without collective and immediate action, the nation risks missing its goal of eliminating viral hepatitis as a significant public health threat by the year 2030.

Central to the proposed strategy is the nationwide introduction of the Hepatitis B birth-dose vaccine. This intervention is specifically targeted at preventing mother-to-child transmission, a critical pathway for the spread of the virus. Dr. Adomako-Boateng argued that integrating this vaccine into the standard neonatal care package is essential for safeguarding future generations. Furthermore, he highlighted the necessity of dismantling the stigma associated with the disease, which often prevents individuals from seeking testing or adhering to treatment regimens. By increasing public awareness and improving access to affordable vaccinations and diagnostics, health officials hope to normalize hepatitis care across all regions.

The health director also urged medical professionals to integrate hepatitis screening into their routine clinical practices, ensuring that every patient encounter is an opportunity for early detection. This sentiment was echoed by Dr. Abena Konadu Yawson, who stressed the importance of early screening to prevent the long-term complications of chronic infection. Dr. Yawson also cautioned the public against behaviors that increase the risk of exposure, advocating for proactive lifestyle choices. Both speakers underscored that community support and education are indispensable components of the fight, as informed citizens are more likely to participate in screening programs and support those living with the condition.

As Ghana moves toward the 2030 elimination target, the call for improved infrastructure and policy support remains urgent. The Ashanti Regional Health Directorate's push for routine screening and better access to treatment reflects a broader national need to prioritize liver health within the public health agenda. With millions already affected, the success of these initiatives will depend on sustained funding, political will, and the effective implementation of the birth-dose vaccine program to break the cycle of infection and ensure a healthier future for all Ghanaians.